BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31777045)

  • 1. A New Scoring System for the Assessment of Neonatal Abstinence Syndrome.
    Kocherlakota P; Qian EC; Patel VC; Mandru C; Vilar RE; Alpan G; La Gamma EF
    Am J Perinatol; 2020 Feb; 37(3):333-340. PubMed ID: 31777045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome.
    Devlin LA; Breeze JL; Terrin N; Gomez Pomar E; Bada H; Finnegan LP; O'Grady KE; Jones HE; Lester B; Davis JM
    JAMA Netw Open; 2020 Apr; 3(4):e202275. PubMed ID: 32267513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA.
    Gomez Pomar E; Finnegan LP; Devlin L; Bada H; Concina VA; Ibonia KT; Westgate PM
    BMJ Open; 2017 Sep; 7(9):e016176. PubMed ID: 28963285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing practice guidelines and education to improve care of infants with neonatal abstinence syndrome.
    Lucas K; Knobel RB
    Adv Neonatal Care; 2012 Feb; 12(1):40-5. PubMed ID: 22301543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nail disease in neonatal abstinence syndrome.
    Flanagan KE; Lal K; Blankenship K; Gorji N; Rork J; Wiss K
    Pediatr Dermatol; 2021 Jul; 38(4):787-793. PubMed ID: 34047407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of hospital discharge coding for neonatal abstinence syndrome.
    Yam P; Lok L; Eastwood J; Maher C; Ward M; Clews S; Falconer J; Oei JL
    Acta Paediatr; 2019 Oct; 108(10):1786-1792. PubMed ID: 30924956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale.
    Jones HE; Seashore C; Johnson E; Horton E; O'Grady KE; Andringa K; Grossman MR; Whalen B; Holmes AV
    Am J Addict; 2016 Aug; 25(5):370-3. PubMed ID: 27287965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Finnegan neonatal abstinence syndrome tool-short form.
    Maguire D; Cline GJ; Parnell L; Tai CY
    Adv Neonatal Care; 2013 Dec; 13(6):430-7. PubMed ID: 24300963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
    McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
    Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome.
    Baloch RQ; Pinto JM; Greenberg P; Kuo YH; Siu A
    J Opioid Manag; 2020; 16(3):189-196. PubMed ID: 32421839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an abbreviated symptom score for the neonatal abstinence syndrome.
    Chervoneva I; Adeniyi-Jones SC; Blanco F; Kraft WK
    J Perinatol; 2020 Jul; 40(7):1031-1040. PubMed ID: 32076111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Possibility of Early Discharge for Newborns Being Monitored for Neonatal Abstinence Syndrome Based on Modified Finnegan Score Distributions.
    Oji-Mmuo CN; Schaefer EW; Liao L; Kaiser JR; Sekhar DL
    Clin Pediatr (Phila); 2019 Jun; 58(6):641-646. PubMed ID: 30813757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Neonatal Abstinence Syndrome Training Program on Nurses' Confidence and Ability to Use the Finnegan Scoring Tool.
    Clark AF
    Nurs Womens Health; 2019 Dec; 23(6):485-493. PubMed ID: 31676285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of newborn behaviours associated with neonatal abstinence syndrome: a hospital-based study.
    Elliott MR; Cunliffe P; Demianczuk N; Robertson CM
    J Obstet Gynaecol Can; 2004 Jan; 26(1):25-34. PubMed ID: 14715123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological monitoring in neonatal abstinence syndrome from cocaine.
    Falsaperla R; Zaami S; Aguglia MG; Romano C; Suppiej A; Memo L
    Ann Ist Super Sanita; 2020; 56(3):390-396. PubMed ID: 32959806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
    Jones HE; Fielder A
    Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid neonatal abstinence syndrome: controversies and implications for practice.
    Wolff K; Perez-Montejano R
    Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escaping the Finnegan - Is it time?
    Singh R; Davis JM
    Semin Fetal Neonatal Med; 2021 Jun; 26(3):101218. PubMed ID: 33663940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.